APPLICATION
ANDA076624
TYPE
ANDA
ORIGINAL APPROVAL
2004-12-03
LATEST ACTION
2019-05-19
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued
Products
MOMETASONE FUROATEDiscontinued
MOMETASONE FUROATE 0.1% · OINTMENT · TOPICAL
Approval history
2019-05-19Labeling · Supplement 8 · standardAP
2015-11-10Labeling · Supplement 6 · standardAP
2004-12-03OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.